Drugs / Human Cadaver Allograft
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT03695939 Comparator | Mar 2019 → Dec 2023 | mixed dermis disorder | XenoTherapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human Cadaver Allograft | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03695939 ↗ |
| Route | Other | “The allograft active comparator will be placed adjacently to the investigational drug, in the same anatomical location, on wound sites following debridement and secured via...” NCT03695939 ↗ |